Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)

BM Technologies Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Operating Revenue	882.11	871.93	827.17	694.08	607.27	520.93
Other Revenue	10.64	10.64	12.09	10.44	9.43	10.26
Revenue	892.76	882.57	839.26	704.53	616.71	531.2
Revenue Growth (YoY)	7.66%	5.16%	19.12%	14.24%	16.10%	14.46%
Cost of Revenue	618.57	609.34	573.93	495.28	438.93	366.76
Gross Profit	274.19	273.23	265.33	209.24	177.78	164.44
Selling, General & Admin	64.27	63.54	60	51.13	52.05	43.64
Research & Development	41.5	40.95	41.95	34.43	26.8	18.12
Other Operating Expenses	-1.46	-1.69	2	2.72	5.85	5.34
Operating Expenses	104.32	102.8	103.99	88.23	84.7	66.93
Operating Income	169.86	170.43	161.34	121.01	93.08	97.51
Interest Expense	-12.59	-12.73	-4.3	-1.21	-1.2	-0.73
Interest & Investment Income	19.06	20.18	11.84	9.05	6.93	4.04
Currency Exchange Gain (Loss)	1.88	1.88	0.37	2.56	-0.28	-1
Other Non Operating Income (Expenses)	-0.74	-0.42	-0.41	-0.38	-0.39	-0.17
EBT Excluding Unusual Items	177.46	179.34	168.84	131.02	98.14	99.65
Impairment of Goodwill	-39.13	-39.13	-	-	-6.13	-
Gain (Loss) on Sale of Investments	-6.33	-3.13	8.51	-2.62	1.74	0.73
Gain (Loss) on Sale of Assets	0.18	0.11	-0.01	-0.27	-2.96	-1.86
Asset Writedown	-0	-0	-1.02	-0.01	-	-
Other Unusual Items	6.13	5.17	9.5	8.29	5.89	8.65
Pretax Income	138.32	142.36	185.82	136.4	96.68	107.17
Income Tax Expense	21.65	21.83	21.2	5.47	11.14	13.65
Earnings From Continuing Operations	116.67	120.52	164.62	130.93	85.54	93.52
Minority Interest in Earnings	0.12	-1.1	-3.09	-0.23	3.72	0.42
Net Income	116.79	119.42	161.54	130.71	89.25	93.94
Net Income to Common	116.79	119.42	161.54	130.71	89.25	93.94
Net Income Growth	-27.89%	-26.07%	23.58%	46.45%	-4.99%	11.34%
Shares Outstanding (Basic)	234	234	234	233	235	230
Shares Outstanding (Diluted)	237	234	241	233	235	230
Shares Change (YoY)	-1.93%	-2.88%	3.29%	-0.63%	1.93%	-1.27%
EPS (Basic)	0.50	0.51	0.69	0.56	0.38	0.41
EPS (Diluted)	0.49	0.51	0.67	0.56	0.38	0.41
EPS Growth	-26.47%	-23.88%	19.64%	47.37%	-6.79%	12.78%
Free Cash Flow	90.21	90.39	77.38	65.5	72.35	64.19
Free Cash Flow Per Share	0.38	0.39	0.32	0.28	0.31	0.28
Dividend Per Share	0.300	0.300	0.250	0.250	0.231	0.192
Dividend Growth	20.00%	20.00%	-	8.32%	20.02%	30.02%
Gross Margin	30.71%	30.96%	31.61%	29.70%	28.83%	30.96%
Operating Margin	19.03%	19.31%	19.22%	17.18%	15.09%	18.36%
Profit Margin	13.08%	13.53%	19.25%	18.55%	14.47%	17.69%
Free Cash Flow Margin	10.11%	10.24%	9.22%	9.30%	11.73%	12.08%
EBITDA	223.53	221.12	200.12	157.07	127.77	129.26
EBITDA Margin	25.04%	25.05%	23.84%	22.30%	20.72%	24.33%
D&A For EBITDA	53.67	50.69	38.78	36.06	34.68	31.76
EBIT	169.86	170.43	161.34	121.01	93.08	97.51
EBIT Margin	19.03%	19.31%	19.22%	17.18%	15.09%	18.36%
Effective Tax Rate	15.65%	15.33%	11.41%	4.01%	11.53%	12.74%
Revenue as Reported	892.76	882.57	839.26	704.53	616.71	531.2
Advertising Expenses	-	0.97	0.86	0.64	0.44	0.55

Updated Oct 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.